Literature DB >> 23592522

p130Cas alters the differentiation potential of mammary luminal progenitors by deregulating c-Kit activity.

Giusy Tornillo1, Angela Rita Elia, Isabella Castellano, Michela Spadaro, Paola Bernabei, Brigitte Bisaro, Maria Del Pilar Camacho-Leal, Alessandra Pincini, Paolo Provero, Anna Sapino, Emilia Turco, Paola Defilippi, Sara Cabodi.   

Abstract

It has recently been proposed that defective differentiation of mammary luminal progenitors predisposes to basal-like breast cancer. However, the molecular and cellular mechanisms involved are still unclear. Here, we describe that the adaptor protein p130Cas is a crucial regulator of mouse mammary epithelial cell (MMEC) differentiation. Using a transgenic mouse model, we show that forced p130Cas overexpression in the luminal progenitor cell compartment results in the expansion of luminal cells, which aberrantly display basal cell features and reduced differentiation in response to lactogenic stimuli. Interestingly, MMECs overexpressing p130Cas exhibit hyperactivation of the tyrosine kinase receptor c-Kit. In addition, we demonstrate that the constitutive c-Kit activation alone mimics p130Cas overexpression, whereas c-Kit downregulation is sufficient to re-establish proper differentiation of p130Cas overexpressing cells. Overall, our data indicate that high levels of p130Cas, via abnormal c-Kit activation, promote mammary luminal cell plasticity, thus providing the conditions for the development of basal-like breast cancer. Consistently, p130Cas is overexpressed in human triple-negative breast cancer, further suggesting that p130Cas upregulation may be a priming event for the onset of basal-like breast cancer.
Copyright © 2013 AlphaMed Press.

Entities:  

Keywords:  Basal-like breast cancer; Differentiation; Mammary luminal progenitor; c-Kit; p130Cas

Mesh:

Substances:

Year:  2013        PMID: 23592522     DOI: 10.1002/stem.1403

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  9 in total

1.  Essential role of SH3GL1 in interleukin-6(IL-6)- and vascular endothelial growth factor (VEGF)-triggered p130cas-mediated proliferation and migration of osteosarcoma cells.

Authors:  En-Qi Li; Jin-Li Zhang
Journal:  Hum Cell       Date:  2017-07-12       Impact factor: 4.174

Review 2.  Materials as stem cell regulators.

Authors:  William L Murphy; Todd C McDevitt; Adam J Engler
Journal:  Nat Mater       Date:  2014-06       Impact factor: 43.841

3.  A truncated phosphorylated p130Cas substrate domain is sufficient to drive breast cancer growth and metastasis formation in vivo.

Authors:  Joerg Kumbrink; Ana de la Cueva; Shefali Soni; Nadja Sailer; Kathrin H Kirsch
Journal:  Tumour Biol       Date:  2016-02-11

4.  Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.

Authors:  Yann Wallez; Stefan J Riedl; Elena B Pasquale
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

Review 5.  CAS proteins in health and disease: an update.

Authors:  Anna S Nikonova; Anna V Gaponova; Alexander E Kudinov; Erica A Golemis
Journal:  IUBMB Life       Date:  2014-06-24       Impact factor: 3.885

Review 6.  Cas proteins: dodgy scaffolding in breast cancer.

Authors:  Giusy Tornillo; Paola Defilippi; Sara Cabodi
Journal:  Breast Cancer Res       Date:  2014       Impact factor: 6.466

7.  Identification of afzelin potential targets in inhibiting triple-negative breast cancer cell migration using reverse docking.

Authors:  Eva Rachmi; Basuki Bambang Purnomo; Agustina Tri Endharti; Loeki Enggar Fitri
Journal:  Porto Biomed J       Date:  2020-11-24

Review 8.  p130Cas/BCAR1 scaffold protein in tissue homeostasis and pathogenesis.

Authors:  Maria del Pilar Camacho Leal; Marianna Sciortino; Giusy Tornillo; Shana Colombo; Paola Defilippi; Sara Cabodi
Journal:  Gene       Date:  2015-02-27       Impact factor: 3.688

9.  Dual Mechanisms of LYN Kinase Dysregulation Drive Aggressive Behavior in Breast Cancer Cells.

Authors:  Giusy Tornillo; Catherine Knowlson; Howard Kendrick; Joe Cooke; Hasan Mirza; Iskander Aurrekoetxea-Rodríguez; Maria D M Vivanco; Niamh E Buckley; Anita Grigoriadis; Matthew J Smalley
Journal:  Cell Rep       Date:  2018-12-26       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.